Advertisements



Strength Seen in Lilly (LLY): Can Its 4.9% Jump Turn into More Strength?

Lilly (LLY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term. Eli Lilly LLY shares rallied 4.9% in the last trading session to close at $310.87. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 7% loss over the past four weeks.Share prices likely rose after the analysts at UBS upgraded the stock’s recommendation to “Buy”. The analysts expect Eli Lilly’s recently approved drug Mounjaro (tirzepatide) has a blockbuster potential. This May, the drug was approved by the FDA for treating type II diabetes. The drug is also being evaluated as a potential treatment for obesity. Earlier this April, Eli Lilly announced data from a late-stage study which showed that treatment with the drug achieved at least 20% body weight reductions in more than half of the study participants. This drugmaker is expected to post quarterly earnings of $1.94 per share in its upcoming report, which represents no change from the year-ago quarter. Revenues are expected to be $7.02 billion, up 3.7% from the year-ago quarter.While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.For Lilly, the consensus EPS estimate for the quarter has been revised 0.6% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on LLY going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Lilly is a member of the Zacks Large Cap Pharmaceuticals industry. One other stock in the same industry, Novartis NVS, finished the last trading session 0.5% lower at $77.14. NVS has returned -7.3% over the past month.Novartis' consensus EPS estimate for the upcoming report has remained unchanged over the past month at $1.57. Compared to the company's year-ago EPS, this represents a change of -8.2%. Novartis currently boasts a Zacks Rank of #3 (Hold). Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Eli Lilly and Company (LLY): Free Stock Analysis Report Novartis AG (NVS): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 23rd, 2022

BTRS Holdings Inc. (BTRS) Moves 60.8% Higher: Will This Strength Last?

BTRS Holdings Inc. (BTRS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road. BTRS Holdings Inc. (BTRS) shares ended the trading session on Wednesday 60.8% higher at $9.28. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 14.3% loss over the past four weeks.This increased investor optimism can be attributed to the news of its acquisition by EQT X fund for $9.5 per share in cash, representing a total enterprise value of $1.7 billion.This company is expected to post quarterly loss of $0.07 per share in its upcoming report, which represents a year-over-year change of -133.3%. Revenues are expected to be $43.62 million, up 33.3% from the year-ago quarter.While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.For BTRS Holdings Inc., the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on BTRS going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>BTRS Holdings Inc. is part of the Zacks Technology Services industry. Block (SQ), another stock in the same industry, closed the Wednesday trading session 7.2% higher at $59.07. SQ has returned -20.2% in the past month.Block's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.26. Compared to the company's year-ago EPS, this represents a change of -29.7%. Block currently boasts a Zacks Rank of #3 (Hold). This Little-Known Semiconductor Stock Could Be Your Portfolio’s Hedge Against Inflation Everyone uses semiconductors. But only a small number of people know what they are and what they do. If you use a smartphone, computer, microwave, digital camera or refrigerator (and that’s just the tip of the iceberg), you have a need for semiconductors. That’s why their importance can’t be overstated and their disruption in the supply chain has such a global effect. But every cloud has a silver lining. Shockwaves to the international supply chain from the global pandemic have unearthed a tremendous opportunity for investors. And today, Zacks' leading stock strategist is revealing the one semiconductor stock that stands to gain the most in a new FREE report. It's yours at no cost and with no obligation.>>Yes, I Want to Help Protect My Portfolio During the RecessionWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report BTRS Holdings Inc. (BTRS): Free Stock Analysis Report Block, Inc. (SQ): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacks15 hr. 29 min. ago

Beacon Roofing (BECN) Stock Jumps 5.6%: Will It Continue to Soar?

Beacon Roofing (BECN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term. Beacon Roofing Supply (BECN) shares ended the last trading session 5.6% higher at $54.89. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 7.1% loss over the past four weeks.The company has been gaining from strategic initiatives and successful execution of technology initiatives in the growing e-commerce platform. It remains on track with the long-term target of generating $1 billion in annual digital sales.This roofing materials distributor is expected to post quarterly earnings of $2.13 per share in its upcoming report, which represents a year-over-year change of +39.2%. Revenues are expected to be $2.34 billion, up 24.8% from the year-ago quarter.Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.For Beacon Roofing, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on BECN going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Beacon Roofing belongs to the Zacks Building Products - Retail industry. Another stock from the same industry, Builders FirstSource (BLDR), closed the last trading session 7.7% higher at $58.46. Over the past month, BLDR has returned -9.3%.Builders FirstSource's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $3.42. Compared to the company's year-ago EPS, this represents a change of +0.9%. Builders FirstSource currently boasts a Zacks Rank of #3 (Hold). FREE Report: The Metaverse is Exploding! Don’t You Want to Cash In? Rising gas prices. The war in Ukraine. America's recession. Inflation. It's no wonder why the metaverse is so popular and growing every day. Becoming Spider Man and fighting Darth Vader is infinitely more appealing than spending over $5 per gallon at the pump. And that appeal is why the metaverse can provide such massive gains for investors. But do you know where to look? Do you know which metaverse stocks to buy and which to avoid? In a new FREE report from Zacks' leading stock specialist, we reveal how you could profit from the internet’s next evolution. Even though the popularity of the metaverse is spreading like wildfire, investors like you can still get in on the ground floor and cash in. Don't miss your chance to get your piece of this innovative $30 trillion opportunity - FREE.>>Yes, I want to know the top metaverse stocks for 2022>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Beacon Roofing Supply, Inc. (BECN): Free Stock Analysis Report Builders FirstSource, Inc. (BLDR): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 29th, 2022

Masco (MAS) Stock Jumps 6.5%: Will It Continue to Soar?

Masco (MAS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. Masco (MAS) shares ended the last trading session 6.5% higher at $48.86. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 10.1% loss over the past four weeks.The company has been gaining from solid brand portfolio and long-term prospect backed by a strong operating margin, expansion through cost productivity and volume leverage.This maker of Behr paint, Delta faucets and other building products is expected to post quarterly earnings of $1.07 per share in its upcoming report, which represents a year-over-year change of +8.1%. Revenues are expected to be $2.27 billion, up 3% from the year-ago quarter.While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.For Masco, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on MAS going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Masco is part of the Zacks Building Products - Miscellaneous industry. Advanced Drainage Systems (WMS), another stock in the same industry, closed the last trading session 4.5% higher at $125.56. WMS has returned -12.5% in the past month.For Advanced Drainage, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $1.88. This represents a change of +113.6% from what the company reported a year ago. Advanced Drainage currently has a Zacks Rank of #1 (Strong Buy). FREE Report: The Metaverse is Exploding! Don’t You Want to Cash In? Rising gas prices. The war in Ukraine. America's recession. Inflation. It's no wonder why the metaverse is so popular and growing every day. Becoming Spider Man and fighting Darth Vader is infinitely more appealing than spending over $5 per gallon at the pump. And that appeal is why the metaverse can provide such massive gains for investors. But do you know where to look? Do you know which metaverse stocks to buy and which to avoid? In a new FREE report from Zacks' leading stock specialist, we reveal how you could profit from the internet’s next evolution. Even though the popularity of the metaverse is spreading like wildfire, investors like you can still get in on the ground floor and cash in. Don't miss your chance to get your piece of this innovative $30 trillion opportunity - FREE.>>Yes, I want to know the top metaverse stocks for 2022>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Masco Corporation (MAS): Free Stock Analysis Report Advanced Drainage Systems, Inc. (WMS): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 29th, 2022

Installed Building Products (IBP) Soars 6.2%: Is Further Upside Left in the Stock?

Installed Building Products (IBP) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road. Installed Building Products (IBP) shares rallied 6.2% in the last trading session to close at $83.78. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 14.5% loss over the past four weeks.The company has been gaining from the strong end-market demand, the continued success of local branches, asset-light business model and proficient acquisition strategies.This residential insulation installer is expected to post quarterly earnings of $2.32 per share in its upcoming report, which represents a year-over-year change of +55.7%. Revenues are expected to be $673.95 million, up 32.2% from the year-ago quarter.While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.For Installed Building Products, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on IBP going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Installed Building Products belongs to the Zacks Building Products - Miscellaneous industry. Another stock from the same industry, TopBuild (BLD), closed the last trading session 6.2% higher at $167.97. Over the past month, BLD has returned -14.4%.TopBuild's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $4.09. Compared to the company's year-ago EPS, this represents a change of +38.6%. TopBuild currently boasts a Zacks Rank of #3 (Hold). FREE Report: The Metaverse is Exploding! Don’t You Want to Cash In? Rising gas prices. The war in Ukraine. America's recession. Inflation. It's no wonder why the metaverse is so popular and growing every day. Becoming Spider Man and fighting Darth Vader is infinitely more appealing than spending over $5 per gallon at the pump. And that appeal is why the metaverse can provide such massive gains for investors. But do you know where to look? Do you know which metaverse stocks to buy and which to avoid? In a new FREE report from Zacks' leading stock specialist, we reveal how you could profit from the internet’s next evolution. Even though the popularity of the metaverse is spreading like wildfire, investors like you can still get in on the ground floor and cash in. Don't miss your chance to get your piece of this innovative $30 trillion opportunity - FREE.>>Yes, I want to know the top metaverse stocks for 2022>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Installed Building Products, Inc. (IBP): Free Stock Analysis Report TopBuild Corp. (BLD): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 29th, 2022

Strength Seen in Hoya Corp. (HOCPY): Can Its 5.6% Jump Turn into More Strength?

Hoya Corp. (HOCPY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. Hoya Corp. HOCPY shares ended the last trading session 5.6% higher at $98.15. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 9.1% loss over the past four weeks.The recent surge in Hoya Corp’s share price can be attributed to the news that it has established a joint venture company with Beijing BOE Vision Electronic Technology co. Ltd. a member of the BOE Group, in China. The joint venture will involve Hoya Corp’s flat panel display business unit.This company is expected to post quarterly earnings of $0.93 per share in its upcoming report, which represents a year-over-year change of -12.3%. Revenues are expected to be $1.39 billion, down 6.2% from the year-ago quarter.Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.For Hoya Corp., the consensus EPS estimate for the quarter has been revised 6.1% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on HOCPY going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Hoya Corp. belongs to the Zacks Electronics - Miscellaneous Products industry. Another stock from the same industry, Flex (FLEX), closed the last trading session 3.4% higher at $17.17. Over the past month, FLEX has returned -7.9%.Flex's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.51. Compared to the company's year-ago EPS, this represents a change of +6.3%. Flex currently boasts a Zacks Rank of #3 (Hold). FREE Report: The Metaverse is Exploding! Don’t You Want to Cash In? Rising gas prices. The war in Ukraine. America's recession. Inflation. It's no wonder why the metaverse is so popular and growing every day. Becoming Spider Man and fighting Darth Vader is infinitely more appealing than spending over $5 per gallon at the pump. And that appeal is why the metaverse can provide such massive gains for investors. But do you know where to look? Do you know which metaverse stocks to buy and which to avoid? In a new FREE report from Zacks' leading stock specialist, we reveal how you could profit from the internet’s next evolution. Even though the popularity of the metaverse is spreading like wildfire, investors like you can still get in on the ground floor and cash in. Don't miss your chance to get your piece of this innovative $30 trillion opportunity - FREE.>>Yes, I want to know the top metaverse stocks for 2022>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Hoya Corp. (HOCPY): Free Stock Analysis Report Flex Ltd. (FLEX): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 29th, 2022

Workiva (WK) Moves 17.6% Higher: Will This Strength Last?

Workiva (WK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. Workiva WK shares rallied 17.6% in the last trading session to close at $76.15. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 4.8% loss over the past four weeks.The recent surge in Workiva’s share price is due to a speculation that the company has drawn a takeover interest from Thomas Bravo and TPG. Reportedly, the two private equity firms held financing discussions with direct lenders to support a potential transaction.This maker of software for managing regulatory filings is expected to post quarterly loss of $0.26 per share in its upcoming report, which represents a year-over-year change of -273.3%. Revenues are expected to be $132.42 million, up 17.5% from the year-ago quarter.While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.For Workiva, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on WK going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Workiva is part of the Zacks Internet - Software industry. KANZHUN LIMITED Sponsored ADR (BZ), another stock in the same industry, closed the last trading session 0.7% higher at $19.39. BZ has returned -15.4% in the past month.For KANZHUN LIMITED Sponsored ADR, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.07. This represents a change of -46.2% from what the company reported a year ago. KANZHUN LIMITED Sponsored ADR currently has a Zacks Rank of #3 (Hold). FREE Report: The Metaverse is Exploding! Don’t You Want to Cash In? Rising gas prices. The war in Ukraine. America's recession. Inflation. It's no wonder why the metaverse is so popular and growing every day. Becoming Spider Man and fighting Darth Vader is infinitely more appealing than spending over $5 per gallon at the pump. And that appeal is why the metaverse can provide such massive gains for investors. But do you know where to look? Do you know which metaverse stocks to buy and which to avoid? In a new FREE report from Zacks' leading stock specialist, we reveal how you could profit from the internet’s next evolution. Even though the popularity of the metaverse is spreading like wildfire, investors like you can still get in on the ground floor and cash in. Don't miss your chance to get your piece of this innovative $30 trillion opportunity - FREE.>>Yes, I want to know the top metaverse stocks for 2022>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Workiva Inc. (WK): Free Stock Analysis Report KANZHUN LIMITED Sponsored ADR (BZ): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 29th, 2022

YmAbs Therapeutics, Inc. (YMAB) Soars 5.2%: Is Further Upside Left in the Stock?

YmAbs Therapeutics, Inc. (YMAB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term. YmAbs Therapeutics, Inc. YMAB shares rallied 5.2% in the last trading session to close at $14.91. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 8.9% loss over the past four weeks.The rise in share prices is attributable to investor expectations on the company’s marketed drugs and pipeline development. Earlier this week, Y-mAbs announced that it has submitted a regulatory application in Brazil seeking approval for its neuroblastoma drug Danyelza (naxitamab). The drug was approved by the FDA under accelerated pathway for treating relapsed or refractory high-risk neuroblastoma in individuals aged one year and older in 2020.This company is expected to post quarterly loss of $0.69 per share in its upcoming report, which represents a year-over-year change of -4.6%. Revenues are expected to be $15.43 million, up 72% from the year-ago quarter.While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.For YmAbs Therapeutics, Inc., the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on YMAB going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>YmAbs Therapeutics, Inc. is part of the Zacks Medical - Biomedical and Genetics industry. Exact Sciences EXAS, another stock in the same industry, closed the last trading session 7.7% higher at $34.44. EXAS has returned -10.2% in the past month.Exact Sciences' consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$1.09. Compared to the company's year-ago EPS, this represents a change of -12.4%. Exact Sciences currently boasts a Zacks Rank of #3 (Hold). FREE Report: The Metaverse is Exploding! Don’t You Want to Cash In? Rising gas prices. The war in Ukraine. America's recession. Inflation. It's no wonder why the metaverse is so popular and growing every day. Becoming Spider Man and fighting Darth Vader is infinitely more appealing than spending over $5 per gallon at the pump. And that appeal is why the metaverse can provide such massive gains for investors. But do you know where to look? Do you know which metaverse stocks to buy and which to avoid? In a new FREE report from Zacks' leading stock specialist, we reveal how you could profit from the internet’s next evolution. Even though the popularity of the metaverse is spreading like wildfire, investors like you can still get in on the ground floor and cash in. Don't miss your chance to get your piece of this innovative $30 trillion opportunity - FREE.>>Yes, I want to know the top metaverse stocks for 2022>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report YmAbs Therapeutics, Inc. (YMAB): Free Stock Analysis Report Exact Sciences Corporation (EXAS): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 29th, 2022

Northern Technologies (NTIC) Moves 5.3% Higher: Will This Strength Last?

Northern Technologies (NTIC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road. Northern Technologies (NTIC) shares rallied 5.3% in the last trading session to close at $12.42. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 1.6% loss over the past four weeks.Optimism over higher global demand for the company’s products on the back of a broader economic recovery from the pandemic is driving the stock higher. The company is benefiting from strong sales for its Zerust business on the back of higher demand and continued recovery of Natur-Tec sales, aided by the reopening of the economies around the world. Investors also appear to be enthused about the company’s recent contract with BP Exploration (Caspian Sea) Limited to supply chemical corrosion protection services for 12 BP storage tanks through December 2025.This rust and corrosion prevention company is expected to post quarterly earnings of $0.13 per share in its upcoming report, which represents a year-over-year change of -23.5%. Revenues are expected to be $19.5 million, up 25.7% from the year-ago quarter.Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.For Northern Technologies, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on NTIC going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Northern Technologies belongs to the Zacks Chemical - Diversified industry. Another stock from the same industry, Huntsman (HUN), closed the last trading session 2.6% higher at $24.75. Over the past month, HUN has returned -16.2%.For Huntsman, the consensus EPS estimate for the upcoming report has changed -22.3% over the past month to $0.79. This represents a change of -26.9% from what the company reported a year ago. Huntsman currently has a Zacks Rank of #3 (Hold). FREE Report: The Metaverse is Exploding! Don’t You Want to Cash In? Rising gas prices. The war in Ukraine. America's recession. Inflation. It's no wonder why the metaverse is so popular and growing every day. Becoming Spider Man and fighting Darth Vader is infinitely more appealing than spending over $5 per gallon at the pump. And that appeal is why the metaverse can provide such massive gains for investors. But do you know where to look? Do you know which metaverse stocks to buy and which to avoid? In a new FREE report from Zacks' leading stock specialist, we reveal how you could profit from the internet’s next evolution. Even though the popularity of the metaverse is spreading like wildfire, investors like you can still get in on the ground floor and cash in. Don't miss your chance to get your piece of this innovative $30 trillion opportunity - FREE.>>Yes, I want to know the top metaverse stocks for 2022>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Northern Technologies International Corporation (NTIC): Free Stock Analysis Report Huntsman Corporation (HUN): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 29th, 2022

Strength Seen in Flex LNG (FLNG): Can Its 8.3% Jump Turn into More Strength?

Flex LNG (FLNG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term. Flex LNG (FLNG) shares ended the last trading session 8.3% higher at $32.86. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 10.8% loss over the past four weeks.The uptick is owing to the buoyancy surrounding the  LNG shipping sector. With demand being very strong, LNG freight rates are continuously moving north.  Driven by this rosy demand scenario, shares of FLNG have gained 40% year to date.This liquefied natural gas shipping company is expected to post quarterly earnings of $0.80 per share in its upcoming report, which represents a year-over-year change of +33.3%. Revenues are expected to be $91.65 million, up 12.1% from the year-ago quarter.While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.For Flex LNG, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on FLNG going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Flex LNG is part of the Zacks Transportation - Shipping industry. Capital Product Partners L.P. (CPLP), another stock in the same industry, closed the last trading session 1% higher at $13.89. CPLP has returned -9.1% in the past month.Capital Product Partners L.P.'s consensus EPS estimate for the upcoming report has remained unchanged over the past month at $1.06. Compared to the company's year-ago EPS, this represents a change of +71%. Capital Product Partners L.P. currently boasts a Zacks Rank of #3 (Hold). FREE Report: The Metaverse is Exploding! Don’t You Want to Cash In? Rising gas prices. The war in Ukraine. America's recession. Inflation. It's no wonder why the metaverse is so popular and growing every day. Becoming Spider Man and fighting Darth Vader is infinitely more appealing than spending over $5 per gallon at the pump. And that appeal is why the metaverse can provide such massive gains for investors. But do you know where to look? Do you know which metaverse stocks to buy and which to avoid? In a new FREE report from Zacks' leading stock specialist, we reveal how you could profit from the internet’s next evolution. Even though the popularity of the metaverse is spreading like wildfire, investors like you can still get in on the ground floor and cash in. Don't miss your chance to get your piece of this innovative $30 trillion opportunity - FREE.>>Yes, I want to know the top metaverse stocks for 2022>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Flex LNG Ltd. (FLNG): Free Stock Analysis Report Capital Product Partners L.P. (CPLP): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 29th, 2022

Tactile Systems Technology (TCMD) Moves 6.6% Higher: Will This Strength Last?

Tactile Systems Technology (TCMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. Tactile Systems Technology TCMD shares rallied 6.6% in the last trading session to close at $8.04. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 10.2% loss over the past four weeks.Tactile Medical scored a strong price rise benefitting from a solid boost in the U.S. equity market. At the close on Sep 28, 2022, the Dow Jones Industrial Average was up 1.88%. The S&P 500 index as well as the NASDAQ Composite index climbed 1.97% and 2.05% respectively.Meanwhile, the company is expected to report its third-quarter 2022 financial results on Nov 7. We expect the company to report a revenue beat of 14.9%.This medical device maker is expected to post quarterly loss of $0.10 per share in its upcoming report, which represents a year-over-year change of -25%. Revenues are expected to be $60.2 million, up 14.7% from the year-ago quarter.While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.For Tactile Systems Technology, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on TCMD going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Tactile Systems Technology is part of the Zacks Medical - Instruments industry. Teleflex TFX, another stock in the same industry, closed the last trading session 3% higher at $207.96. TFX has returned -9.4% in the past month.For Teleflex, the consensus EPS estimate for the upcoming report has changed -0.5% over the past month to $3.10. This represents a change of -11.7% from what the company reported a year ago. Teleflex currently has a Zacks Rank of #4 (Sell). FREE Report: The Metaverse is Exploding! Don’t You Want to Cash In? Rising gas prices. The war in Ukraine. America's recession. Inflation. It's no wonder why the metaverse is so popular and growing every day. Becoming Spider Man and fighting Darth Vader is infinitely more appealing than spending over $5 per gallon at the pump. And that appeal is why the metaverse can provide such massive gains for investors. But do you know where to look? Do you know which metaverse stocks to buy and which to avoid? In a new FREE report from Zacks' leading stock specialist, we reveal how you could profit from the internet’s next evolution. Even though the popularity of the metaverse is spreading like wildfire, investors like you can still get in on the ground floor and cash in. Don't miss your chance to get your piece of this innovative $30 trillion opportunity - FREE.>>Yes, I want to know the top metaverse stocks for 2022>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Tactile Systems Technology, Inc. (TCMD): Free Stock Analysis Report Teleflex Incorporated (TFX): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 29th, 2022

AxoGen (AXGN) Soars 8.6%: Is Further Upside Left in the Stock?

AxoGen (AXGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term. AxoGen (AXGN) shares soared 8.6% in the last trading session to close at $12.25. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 22% gain over the past four weeks.Axogen scored a strong price rise on investors’ optimism surrounding the company’s participation in the 77th Annual Meeting of the American Society for Surgery of the Hand (ASSH). During the conference Axogen will host an industry forum symposium entitled Late-Breaking, State-of-the-Art Nerve Reconstruction Data: The How and Why of Implementing this New Data into Your Clinical Practice.Further, the company has also benefitted from a solid boost in the U.S. equity market yesterday. At the close on Sep 28, 2022, the Dow Jones Industrial Average was up 1.88%. The S&P 500 index as well as the NASDAQ Composite index climbed 1.97% and 2.05% respectively.This regenerative medicine company is expected to post quarterly loss of $0.15 per share in its upcoming report, which represents a year-over-year change of -66.7%. Revenues are expected to be $36.1 million, up 15.7% from the year-ago quarter.Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.For AxoGen, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on AXGN going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>AxoGen is a member of the Zacks Medical - Instruments industry. One other stock in the same industry, Asensus Surgical ASXC, finished the last trading session 5.5% higher at $0.44. ASXC has returned -23.7% over the past month.Asensus Surgical's consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.07. Compared to the company's year-ago EPS, this represents a change of -16.7%. Asensus Surgical currently boasts a Zacks Rank of #2 (Buy). FREE Report: The Metaverse is Exploding! Don’t You Want to Cash In? Rising gas prices. The war in Ukraine. America's recession. Inflation. It's no wonder why the metaverse is so popular and growing every day. Becoming Spider Man and fighting Darth Vader is infinitely more appealing than spending over $5 per gallon at the pump. And that appeal is why the metaverse can provide such massive gains for investors. But do you know where to look? Do you know which metaverse stocks to buy and which to avoid? In a new FREE report from Zacks' leading stock specialist, we reveal how you could profit from the internet’s next evolution. Even though the popularity of the metaverse is spreading like wildfire, investors like you can still get in on the ground floor and cash in. Don't miss your chance to get your piece of this innovative $30 trillion opportunity - FREE.>>Yes, I want to know the top metaverse stocks for 2022>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AxoGen, Inc. (AXGN): Free Stock Analysis Report Asensus Surgical, Inc. (ASXC): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 29th, 2022

Kilroy Realty (KRC) Surges 5.3%: Is This an Indication of Further Gains?

Kilroy Realty (KRC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in FFO estimate revisions may not translate into further price increase in the near term. Kilroy Realty (KRC) shares ended the last trading session 5.3% higher at $43.45. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 15.9% loss over the past four weeks.The increased optimism can be attributed to recovering industry fundamentals. Also, it stems from investors’ favorable view on the industry amid an anticipation that the Fed could adopt a reverse course of action with respect to interest rates, if economic trends tip into a deep-recession mode in the future.This real estate investment trust is expected to post quarterly funds from operations (FFO) of $1.14 per share in its upcoming report, which represents a year-over-year change of +16.3%. Revenues are expected to be $264.45 million, up 13.8% from the year-ago quarter.While FFO and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in FFO estimate revisions and near-term stock price movements.For Kilroy Realty, the consensus FFO per share estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in FFO estimate revisions. So, make sure to keep an eye on KRC going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Kilroy Realty is a member of the Zacks REIT and Equity Trust - Other industry. One other stock in the same industry, Postal Realty Trust (PSTL), finished the last trading session 4% higher at $15.01. PSTL has returned -3.7% over the past month.Postal Realty Trust's consensus FFO per share estimate for the upcoming report has changed -2.4% over the past month to $0.25. Compared to the company's year-ago FFO per share, this represents a change of -7.4%. Postal Realty Trust currently boasts a Zacks Rank of #3 (Hold). FREE Report: The Metaverse is Exploding! Don’t You Want to Cash In? Rising gas prices. The war in Ukraine. America's recession. Inflation. It's no wonder why the metaverse is so popular and growing every day. Becoming Spider Man and fighting Darth Vader is infinitely more appealing than spending over $5 per gallon at the pump. And that appeal is why the metaverse can provide such massive gains for investors. But do you know where to look? Do you know which metaverse stocks to buy and which to avoid? In a new FREE report from Zacks' leading stock specialist, we reveal how you could profit from the internet’s next evolution. Even though the popularity of the metaverse is spreading like wildfire, investors like you can still get in on the ground floor and cash in. Don't miss your chance to get your piece of this innovative $30 trillion opportunity - FREE.>>Yes, I want to know the top metaverse stocks for 2022>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Kilroy Realty Corporation (KRC): Free Stock Analysis Report Postal Realty Trust, Inc. (PSTL): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 29th, 2022

Strength Seen in Triumph Group (TGI): Can Its 6.2% Jump Turn into More Strength?

Triumph Group (TGI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. Triumph Group (TGI) shares rallied 6.2% in the last trading session to close at $9.44. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 32.2% loss over the past four weeks.The latest uptick in the share price performance of Triumph Group can be attributed to the latest addition of a member, Cynthia Egnotovich, to the company’s board, as an independent director.This aircraft supplier is expected to post quarterly loss of $0.04 per share in its upcoming report, which represents a year-over-year change of -140%. Revenues are expected to be $296.57 million, down 17% from the year-ago quarter.While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.For Triumph Group, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on TGI going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Triumph Group is part of the Zacks Aerospace - Defense Equipment industry. AerSale Corporation (ASLE), another stock in the same industry, closed the last trading session 2.2% higher at $18.85. ASLE has returned -6.4% in the past month.For AerSale Corporation, the consensus EPS estimate for the upcoming report has changed -10% over the past month to $0.05. This represents a change of -77.3% from what the company reported a year ago. AerSale Corporation currently has a Zacks Rank of #1 (Strong Buy). FREE Report: The Metaverse is Exploding! Don’t You Want to Cash In? Rising gas prices. The war in Ukraine. America's recession. Inflation. It's no wonder why the metaverse is so popular and growing every day. Becoming Spider Man and fighting Darth Vader is infinitely more appealing than spending over $5 per gallon at the pump. And that appeal is why the metaverse can provide such massive gains for investors. But do you know where to look? Do you know which metaverse stocks to buy and which to avoid? In a new FREE report from Zacks' leading stock specialist, we reveal how you could profit from the internet’s next evolution. Even though the popularity of the metaverse is spreading like wildfire, investors like you can still get in on the ground floor and cash in. Don't miss your chance to get your piece of this innovative $30 trillion opportunity - FREE.>>Yes, I want to know the top metaverse stocks for 2022>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Triumph Group, Inc. (TGI): Free Stock Analysis Report AerSale Corporation (ASLE): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 29th, 2022

Denali Therapeutics Inc. (DNLI) Moves 17.7% Higher: Will This Strength Last?

Denali Therapeutics Inc. (DNLI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term. Denali Therapeutics Inc. (DNLI) shares ended the last trading session 17.7% higher at $32.12. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 1.8% loss over the past four weeks.Shares gained as investors are impressed by the company’s progress with its pipeline candidates.  Denali possesses a notable portfolio of targeted therapeutic candidates for neurodegenerative diseases which promise potential. This company is expected to post quarterly loss of $0.83 per share in its upcoming report, which represents a year-over-year change of -20.3%. Revenues are expected to be $10.06 million, up 90.1% from the year-ago quarter.While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.For Denali Therapeutics Inc., the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on DNLI going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Denali Therapeutics Inc. belongs to the Zacks Medical - Biomedical and Genetics industry. Another stock from the same industry, Zymeworks Inc. (ZYME), closed the last trading session 1.3% higher at $5.58. Over the past month, ZYME has returned -14.2%.Zymeworks Inc.'s consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.86. Compared to the company's year-ago EPS, this represents a change of +31.2%. Zymeworks Inc. currently boasts a Zacks Rank of #3 (Hold). FREE Report: The Metaverse is Exploding! Don’t You Want to Cash In? Rising gas prices. The war in Ukraine. America's recession. Inflation. It's no wonder why the metaverse is so popular and growing every day. Becoming Spider Man and fighting Darth Vader is infinitely more appealing than spending over $5 per gallon at the pump. And that appeal is why the metaverse can provide such massive gains for investors. But do you know where to look? Do you know which metaverse stocks to buy and which to avoid? In a new FREE report from Zacks' leading stock specialist, we reveal how you could profit from the internet’s next evolution. Even though the popularity of the metaverse is spreading like wildfire, investors like you can still get in on the ground floor and cash in. Don't miss your chance to get your piece of this innovative $30 trillion opportunity - FREE.>>Yes, I want to know the top metaverse stocks for 2022>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Denali Therapeutics Inc. (DNLI): Free Stock Analysis Report Zymeworks Inc. (ZYME): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 29th, 2022

Strength Seen in Silk Road Medical (SILK): Can Its 9.3% Jump Turn into More Strength?

Silk Road Medical (SILK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. Silk Road Medical SILK shares rallied 9.3% in the last trading session to close at $47.94. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 12.5% gain over the past four weeks.Silk Road Medical recorded a strong price rise on investors’ optimism surrounding a bullish report (released on Sep 27) published in PULSE 2.0. The report says, Stifel analyst Rick Wise reiterated a ‘Buy’ rating on the stock after a factory tour, interactions with CEO Erica Rogers, and a TCAR user panel. As per the report, Wise was encouraged about the company’s growth and innovation outlook.This medical device maker is expected to post quarterly loss of $0.44 per share in its upcoming report, which represents a year-over-year change of -10%. Revenues are expected to be $33.84 million, up 37% from the year-ago quarter.Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.For Silk Road Medical, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on SILK going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Silk Road Medical is part of the Zacks Medical - Instruments industry. OrthoPediatrics KIDS, another stock in the same industry, closed the last trading session 4.7% higher at $47.21. KIDS has returned -10.1% in the past month.For OrthoPediatrics, the consensus EPS estimate for the upcoming report has changed +2.6% over the past month to -$0.19. This represents a change of -26.7% from what the company reported a year ago. OrthoPediatrics currently has a Zacks Rank of #3 (Hold). FREE Report: The Metaverse is Exploding! Don’t You Want to Cash In? Rising gas prices. The war in Ukraine. America's recession. Inflation. It's no wonder why the metaverse is so popular and growing every day. Becoming Spider Man and fighting Darth Vader is infinitely more appealing than spending over $5 per gallon at the pump. And that appeal is why the metaverse can provide such massive gains for investors. But do you know where to look? Do you know which metaverse stocks to buy and which to avoid? In a new FREE report from Zacks' leading stock specialist, we reveal how you could profit from the internet’s next evolution. Even though the popularity of the metaverse is spreading like wildfire, investors like you can still get in on the ground floor and cash in. Don't miss your chance to get your piece of this innovative $30 trillion opportunity - FREE.>>Yes, I want to know the top metaverse stocks for 2022>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Silk Road Medical, Inc. (SILK): Free Stock Analysis Report OrthoPediatrics Corp. (KIDS): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 29th, 2022

Alphatec (ATEC) Soars 7%: Is Further Upside Left in the Stock?

Alphatec (ATEC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road. Alphatec ATEC shares rallied 7% in the last trading session to close at $8.67. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 4.8% gain over the past four weeks.Alphatec recorded a strong price rise on investors’ optimism surrounding a bullish Morgan Stanley report. Going by a PULSE 2.0 article, Morgan Stanley analyst Drew Ranieri has initiated coverage of Alphatec observing the company’s premium above-peer growth, that should continue for the foreseeable future with meaningful spine market share gains ahead.This medical equipment and supplies holding company is expected to post quarterly loss of $0.30 per share in its upcoming report, which represents a year-over-year change of +30.2%. Revenues are expected to be $81.8 million, up 30.1% from the year-ago quarter.While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.For Alphatec, the consensus EPS estimate for the quarter has been revised 8.9% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on ATEC going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Alphatec belongs to the Zacks Medical - Instruments industry. Another stock from the same industry, 908 Devices Inc. MASS, closed the last trading session 8.9% higher at $16.54. Over the past month, MASS has returned -21.1%.908 Devices Inc.'s consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.22. Compared to the company's year-ago EPS, this represents a change of -15.8%. 908 Devices Inc. currently boasts a Zacks Rank of #3 (Hold). FREE Report: The Metaverse is Exploding! Don’t You Want to Cash In? Rising gas prices. The war in Ukraine. America's recession. Inflation. It's no wonder why the metaverse is so popular and growing every day. Becoming Spider Man and fighting Darth Vader is infinitely more appealing than spending over $5 per gallon at the pump. And that appeal is why the metaverse can provide such massive gains for investors. But do you know where to look? Do you know which metaverse stocks to buy and which to avoid? In a new FREE report from Zacks' leading stock specialist, we reveal how you could profit from the internet’s next evolution. Even though the popularity of the metaverse is spreading like wildfire, investors like you can still get in on the ground floor and cash in. Don't miss your chance to get your piece of this innovative $30 trillion opportunity - FREE.>>Yes, I want to know the top metaverse stocks for 2022>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Alphatec Holdings, Inc. (ATEC): Free Stock Analysis Report 908 Devices Inc. (MASS): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 29th, 2022

Sabra (SBRA) Stock Jumps 5.5%: Will It Continue to Soar?

Sabra (SBRA) was a big mover last session on higher-than-average trading volume. The latest trend in FFO estimate revisions might help the stock continue moving higher in the near term. Sabra Healthcare (SBRA) shares ended the last trading session 5.5% higher at $13.20. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 16.9% loss over the past four weeks.The increased optimism can be attributed to recovering industry fundamentals. Also, it stems from investors’ favorable view on the industry amid an anticipation that the Fed could adopt a reverse course of action with respect to interest rates, if economic trends tip into a deep-recession mode in the future.This health care real estate investment trust is expected to post quarterly funds from operations (FFO) of $0.38 per share in its upcoming report, which represents no change from the year-ago quarter. Revenues are expected to be $157.48 million, up 22.5% from the year-ago quarter.While FFO and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in FFO estimate revisions and near-term stock price movements.For Sabra, the consensus FFO per share estimate for the quarter has been revised 0.7% higher over the last 30 days to the current level. And a positive trend in FFO estimate revision usually translates into price appreciation. So, make sure to keep an eye on SBRA going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Sabra belongs to the Zacks REIT and Equity Trust - Other industry. Another stock from the same industry, CareTrust REIT (CTRE), closed the last trading session 2.8% higher at $18.21. Over the past month, CTRE has returned -17.4%.For CareTrust REIT, the consensus FFO per share estimate for the upcoming report has changed -1.7% over the past month to $0.38. This represents no change from what the company reported a year ago. CareTrust REIT currently has a Zacks Rank of #3 (Hold). FREE Report: The Metaverse is Exploding! Don’t You Want to Cash In? Rising gas prices. The war in Ukraine. America's recession. Inflation. It's no wonder why the metaverse is so popular and growing every day. Becoming Spider Man and fighting Darth Vader is infinitely more appealing than spending over $5 per gallon at the pump. And that appeal is why the metaverse can provide such massive gains for investors. But do you know where to look? Do you know which metaverse stocks to buy and which to avoid? In a new FREE report from Zacks' leading stock specialist, we reveal how you could profit from the internet’s next evolution. Even though the popularity of the metaverse is spreading like wildfire, investors like you can still get in on the ground floor and cash in. Don't miss your chance to get your piece of this innovative $30 trillion opportunity - FREE.>>Yes, I want to know the top metaverse stocks for 2022>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Sabra Healthcare REIT, Inc. (SBRA): Free Stock Analysis Report CareTrust REIT, Inc. (CTRE): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 29th, 2022

Macerich (MAC) Moves 5.7% Higher: Will This Strength Last?

Macerich (MAC) was a big mover last session on higher-than-average trading volume. The latest trend in FFO estimate revisions might not help the stock continue moving higher in the near term. Macerich (MAC) shares rallied 5.7% in the last trading session to close at $8.17. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 20.7% loss over the past four weeks.The increased optimism can be attributed to recovering industry fundamentals. Also, it stems from investors’ favorable view on the industry amid an anticipation that the Fed could adopt a reverse course of action with respect to interest rates, if economic trends tip into a deep-recession mode in the future.This shopping center real estate investment trust is expected to post quarterly funds from operations (FFO) of $0.47 per share in its upcoming report, which represents a year-over-year change of +4.4%. Revenues are expected to be $215.08 million, up 1.4% from the year-ago quarter.While FFO and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in FFO estimate revisions and near-term stock price movements.For Macerich, the consensus FFO per share estimate for the quarter has been revised 0.8% lower over the last 30 days to the current level. And a negative trend in FFO estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on MAC going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Macerich is part of the Zacks REIT and Equity Trust - Retail industry. Store Capital (STOR), another stock in the same industry, closed the last trading session 0.9% higher at $31.90. STOR has returned 16.5% in the past month.For Store Capital, the consensus FFO per share estimate for the upcoming report has changed +1.6% over the past month to $0.57. This represents a change of +14% from what the company reported a year ago. Store Capital currently has a Zacks Rank of #2 (Buy). FREE Report: The Metaverse is Exploding! Don’t You Want to Cash In? Rising gas prices. The war in Ukraine. America's recession. Inflation. It's no wonder why the metaverse is so popular and growing every day. Becoming Spider Man and fighting Darth Vader is infinitely more appealing than spending over $5 per gallon at the pump. And that appeal is why the metaverse can provide such massive gains for investors. But do you know where to look? Do you know which metaverse stocks to buy and which to avoid? In a new FREE report from Zacks' leading stock specialist, we reveal how you could profit from the internet’s next evolution. Even though the popularity of the metaverse is spreading like wildfire, investors like you can still get in on the ground floor and cash in. Don't miss your chance to get your piece of this innovative $30 trillion opportunity - FREE.>>Yes, I want to know the top metaverse stocks for 2022>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Macerich Company The (MAC): Free Stock Analysis Report STORE Capital Corporation (STOR): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 29th, 2022

Strength Seen in Host Hotels (HST): Can Its 5% Jump Turn into More Strength?

Host Hotels (HST) witnessed a jump in share price last session on above-average trading volume. The latest trend in FFO estimate revisions for the stock suggests that there could be more strength down the road. Host Hotels (HST) shares rallied 5% in the last trading session to close at $16.55. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 11.8% loss over the past four weeks.The increased optimism can be attributed to recovering industry fundamentals. Also, it stems from investors’ favorable view on the industry amid an anticipation that the Fed could adopt a reverse course of action with respect to interest rates, if economic trends tip into a deep-recession mode in the future.This lodging real estate investment trust is expected to post quarterly funds from operations (FFO) of $0.40 per share in its upcoming report, which represents a year-over-year change of +100%. Revenues are expected to be $1.19 billion, up 40.9% from the year-ago quarter.FFO and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in FFO estimate revisions are strongly correlated with near-term stock price movements.For Host Hotels, the consensus FFO per share estimate for the quarter has been revised 1.4% higher over the last 30 days to the current level. And a positive trend in FFO estimate revision usually translates into price appreciation. So, make sure to keep an eye on HST going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Host Hotels is part of the Zacks REIT and Equity Trust - Other industry. Corporate Office Properties (OFC), another stock in the same industry, closed the last trading session 2.2% higher at $23.59. OFC has returned -12.4% in the past month.For Corporate Office Properties, the consensus FFO per share estimate for the upcoming report has changed +0.3% over the past month to $0.58. This represents a change of +1.8% from what the company reported a year ago. Corporate Office Properties currently has a Zacks Rank of #2 (Buy). FREE Report: The Metaverse is Exploding! Don’t You Want to Cash In? Rising gas prices. The war in Ukraine. America's recession. Inflation. It's no wonder why the metaverse is so popular and growing every day. Becoming Spider Man and fighting Darth Vader is infinitely more appealing than spending over $5 per gallon at the pump. And that appeal is why the metaverse can provide such massive gains for investors. But do you know where to look? Do you know which metaverse stocks to buy and which to avoid? In a new FREE report from Zacks' leading stock specialist, we reveal how you could profit from the internet’s next evolution. Even though the popularity of the metaverse is spreading like wildfire, investors like you can still get in on the ground floor and cash in. Don't miss your chance to get your piece of this innovative $30 trillion opportunity - FREE.>>Yes, I want to know the top metaverse stocks for 2022>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Host Hotels & Resorts, Inc. (HST): Free Stock Analysis Report Corporate Office Properties Trust (OFC): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 29th, 2022

Morphic Holding, Inc. (MORF) Moves 7.3% Higher: Will This Strength Last?

Morphic Holding, Inc. (MORF) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. Morphic Holding, Inc. (MORF) shares rallied 7.3% in the last trading session to close at $28.77. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 2.4% loss over the past four weeks.Last month, the company reported robust financial results for the second quarter of 2022. This might have been driving the share price rally.This company is expected to post quarterly loss of $0.80 per share in its upcoming report, which represents a year-over-year change of -15.9%. Revenues are expected to be $3.83 million, up 22.9% from the year-ago quarter.While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.For Morphic Holding, Inc., the consensus EPS estimate for the quarter has been revised 3% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on MORF going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Morphic Holding, Inc. is part of the Zacks Medical - Biomedical and Genetics industry. Sorrento Therapeutics (SRNE), another stock in the same industry, closed the last trading session 9% higher at $1.69. SRNE has returned -20.1% in the past month.For Sorrento Therapeutics, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.21. This represents a change of +47.5% from what the company reported a year ago. Sorrento Therapeutics currently has a Zacks Rank of #4 (Sell). FREE Report: The Metaverse is Exploding! Don’t You Want to Cash In? Rising gas prices. The war in Ukraine. America's recession. Inflation. It's no wonder why the metaverse is so popular and growing every day. Becoming Spider Man and fighting Darth Vader is infinitely more appealing than spending over $5 per gallon at the pump. And that appeal is why the metaverse can provide such massive gains for investors. But do you know where to look? Do you know which metaverse stocks to buy and which to avoid? In a new FREE report from Zacks' leading stock specialist, we reveal how you could profit from the internet’s next evolution. Even though the popularity of the metaverse is spreading like wildfire, investors like you can still get in on the ground floor and cash in. Don't miss your chance to get your piece of this innovative $30 trillion opportunity - FREE.>>Yes, I want to know the top metaverse stocks for 2022>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Morphic Holding, Inc. (MORF): Free Stock Analysis Report Sorrento Therapeutics, Inc. (SRNE): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 29th, 2022